eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | progressive supranuclear palsy |
| Comorbidity | C0497327|dementia |
| Sentences | 4 |
| PubMedID- 20129321 | Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: clinical observations as a basis for power calculations and safety analysis. |
| PubMedID- 20798538 | Obsessive-compulsive behavior as a symptom of dementia in progressive supranuclear palsy. |
| PubMedID- 24304186 | The study employed a cross-disease, cross-species approach to identify mirna that were either specifically dysregulated in msa or were commonly dysregulated in neurodegenerative conditions such as alzheimer's disease, dementia with lewy bodies, progressive supranuclear palsy and corticobasal degeneration or the tg mouse model equivalents of these disorders. |
| PubMedID- 21626553 | During the last decades, atypical parkinsonian disorders such as multiple system atrophy, dementia with lewy bodies, progressive supranuclear palsy, and corticobasal degeneration along with secondary parkinsonian disorders have been increasingly recognized as important causes of parkinsonism. |
Page: 1